Doryx Indirect Purchasers Denied Cert. In Warner Antitrust Suit

Law360, New York (November 20, 2013, 9:13 PM EST) -- A Pennsylvania federal judge on Wednesday denied a bid to certify a proposed class of indirect purchasers who are accusing Warner Chilcott PLC of making small tweaks to its severe acne medication Doryx as a tactic to stave off generics.

U.S. District Judge Paul Diamond denied a motion for class certification by the International Brotherhood of Electrical Workers Local 38, Health and Welfare Fund — a third-party payer for beneficiaries’ prescription medications — which sought to certify a class of indirect purchasers, according to the order....
To view the full article, register now.